Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P250008/S001

Claire OCT System

Perimeter Medical Imaging Ai, Inc. · Decision date Aug 10, 2026

FDA DECISIONP250008/S001

What did the FDA approve?

FDA records P250008/S001 as a supplement to PMA P250008, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Aug 10, 2026.

FDA approval order statement

Approval for a manufacturing site located at RBC Development, LLC (dba Vantage MedTech / RBC Medical Innovations), located at 17100 W 118th Terrace, Olathe, KS 66061, performing cart assembly, consumable (Specimen Immobilizer) assembly, receiving inspection, and tech services and laboratory functions at this facility.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
General, Plastic Surgery
Decision date
Aug 10, 2026
FDA change category
Location Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P250008/S001
Regulatory pathway
PMA supplement
Product code
SHH
Decision code
APPR
Decision date
Aug 10, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: OCT imaging system with AI/ML software for adjunctive detection of breast cancer.

Product code
SHH
FDA device class
3

For the original device and its historical approval scope, see PMA P250008. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P250008 · Original PMA

    Claire OCT System

  2. P250008/S001 received

    Application receipt date recorded by FDA.

  3. P250008/S001 · FDA decision

    Normal 180 Day Track No User Fee

Timeline entries are records held by MedtechLedger for P250008. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P250008

Product / regulatory recordCompanyPathwayDecision dateSource
Perimeter Medical Imaging Ai, Inc.PMA approvalMar 3, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Perimeter Medical Imaging Ai, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
555 Richmond St. W, Suite 511, Toronto, M5V 3B1

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records